The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Intention to treat – who should use ITT?
Open accessAbstract
In the clinical researcher's perfect world every patient entered into a randomised controlled clinical trial (RCT) would satisfy all entry criteria, would complete their allocated treatment as described in the protocol, and would contribute data records which were complete in all respects. In practice it is doubtful if this ideal is ever achieved, and hence strategies have been developed for the analysis of RCTs which seek to protect their inferential basis from consequent biases. Such a strategy is 'intention to treat' (ITT) which is frequently advocated as the preferred approach to analysis. This is particularly so for major trials designed to establish definitively the efficacy and safety of a new medication or medical procedure. Indeed ITT has been endorsed in regulatory guidelines in Europe and the USA (Nordic Council on Medicines, 1989; Food & Drug Administration, 1988). But is ITT always the preferred approach? Can it always be satisfactorily applied? Is it a well-defined and well understood concept? The subject of ITT regularly arouses debate and controversy. In particular the idea that a patient who has been randomised to treatment A, but actually receives treatment B, should be assigned to the group who received A for analysis purposes is totally incomprehensible to some. This controversy is fuelled by the fact that there are a large number of clinical trials, particularly in the early phases of research, for which ITT would indeed be inappropriate. Further fuel is added by the different attitudes to ITT in different research environments it is a constant concern in the later phases of drug regulation, for example, whereas research workers in the Medical Research Council generally show greater flexibility, probably because they are less concerned with satisfying conservative regulatory requirements. It has even been argued that ITT encourages sloppiness 'Whatever we do, give the treatment or not, it is OK since the analysis is by ITT!'. ITT came to prominence in connection with long-term RCTs with mortality as their major end-point. Peto and co-workers laid out the general principles for the design and analysis of such studies in their comprehensive and highly influential publications in this journal (Peto et al., 1976, 1977). They did not use the term 'intention to treat' but did advocate that 'even patients who do not get the proper treatment must not be withdrawn from the analysis'. Their guidance is detailed: the various ways in which patients may fail to complete the study as per protocol are all discussed, together with the possibility that the patients who so fail may differ in characteristics, or numbers, from treatment arm to treatment arm. Such differences are the source of the bias which ITT attempts to avoid any analysis which omits patients is open to bias because it no longer compares the groups as randomised. However, although Peto and coworkers do recommend that all properly randomised patients should be included in the analysis regardless of protocol deviation, they do leave open the possibility for some inappropriately randomised patients to be excluded, and thus stop short of espousing the inclusion of all randomised patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Cited by
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.001 · Cited by 2,345
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Intention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921
Metadata
- Authors
- Lewis, J., & Machin, D.
- Venue
- British Journal of Cancer
- Published
- 1993-10-01
- Volume
- 68
- Issue
- 4
- Pages
- 647-650
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2044763202
- Cited by
- 235
- References
- 1
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intention to treat – who should use ITT? https://app.cochat.ai/papers/10.1038/bjc.1993.402
- The paper
- Lewis, J., & Machin, D. (1993). Intention to treat – who should use ITT? British Journal of Cancer. https://doi.org/10.1038/bjc.1993.402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.